Novo Nordisk
NVO
#65
Rank
HK$1.891 T
Marketcap
HK$368.51
Share price
-6.18%
Change (1 day)
-41.80%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2025 (TTM): HK$162.53 Billion

According to Novo Nordisk's latest financial reports the company's current earnings are HK$47.21 Billion. In 2024 the company made an earning of HK$147.79 Billion, an increase over its 2023 earnings that were of HK$120.31 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) HK$162.53 B9.97%
2024 HK$147.79 B22.84%
2023 HK$120.31 B57.81%
2022 HK$76.24 B5.24%
2021 HK$72.44 B12.38%
2020 HK$64.46 B13.11%
2019 HK$56.99 B-3.45%
2018 HK$59.03 B1.88%
2017 HK$57.93 B4.3%
2016 HK$55.54 B10.32%
2015 HK$50.35 B7.47%
2014 HK$46.85 B3.4%
2013 HK$45.31 B19.09%
2012 HK$38.04 B15.58%
2011 HK$32.92 B16.58%
2010 HK$28.24 B25.66%
2009 HK$22.47 B10.68%
2008 HK$20.30 B55.82%
2007 HK$13.03 B7.02%
2006 HK$12.17 B19.05%
2005 HK$10.22 B10.55%
2004 HK$9.25 B
2002 HK$6.51 B-14.39%
2001 HK$7.60 B-52.82%
2000 HK$16.12 B250%
1999 HK$4.60 B31.21%
1998 HK$3.51 B34.31%
1997 HK$2.61 B11.46%
1996 HK$2.34 B9.03%
1995 HK$2.15 B-3.15%
1994 HK$2.22 B-0.67%
1993 HK$2.23 B45.38%
1992 HK$1.53 B-13.81%
1991 HK$1.78 B37.12%
1990 HK$1.30 B-0.79%
1989 HK$1.31 B26.2%
1988 HK$1.03 B24.97%
1987 HK$0.83 B-0.9%
1986 HK$0.83 B-7.78%
1985 HK$0.91 B24.87%
1984 HK$0.72 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
HK$92.55 B-43.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$175.73 B 7.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$71.06 B-56.34%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
HK$62.73 B-61.46%๐Ÿ‡บ๐Ÿ‡ธ USA